HomeProductsBioactive CompoundsCell CycleAurora KinaseCAS 945595-80-2
Chemical structure of CAS 945595-80-2

N-(4-((3-(2-Amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine

CAS No.945595-80-2
MDL No.MFCD18633194
MFC28H21N7OS
MW503.60
InChI KeyIVUGFMLRJOCGAS-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.945595-80-2
Product NameN-(4-((3-(2-Amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine

Biological Targets

AURKB·AURKC·AURKA

Associated Conditions

cancer·myeloid leukemia
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

AMG900 as novel inhibitor of the translationally controlled tumor protein.

Chemico-biological interactions • Vol. 334 • 2021
PMID: 33259807DOI: 10.1016/j.cbi.2020.109349

Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance.

Journal of molecular biology • Vol. 429, Issue 4 • 2017
PMID: 28043854DOI: 10.1016/j.jmb.2016.12.019

In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases.

Xenobiotica; the fate of foreign compounds in biological systems • Vol. 41, Issue 5 • 2011
PMID: 21294625DOI: 10.3109/00498254.2010.548534

Gender effects on rat metabolism of AMG 900, an orally available small molecule aurora kinase inhibitor.

Drug metabolism letters • Vol. 5, Issue 4 • 2011
PMID: 22022868DOI: 10.2174/187231211798472557

Documentation